Joshua Thomas Thaden, MD, PhD

Assistant Professor of Medicine
Campus mail DUMC Box 102359, Durham, NC 27710
Email address joshua.thaden@duke.edu

Education and Training

  • Fellowship in Infectious Diseases, Medicine, Duke University School of Medicine, 2013 - 2017
  • Internal Medicine Residency, Medicine, Duke University School of Medicine, 2011 - 2013
  • Ph.D., Boston University, 2011
  • M.D., Boston University, 2011

Publications

Maskarinec, S. A., L. P. Park, F. Ruffin, N. A. Turner, N. Patel, E. M. Eichenberger, D. van Duin, T. Lodise, V. G. Fowler, and J. T. Thaden. “Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia.” Clin Microbiol Infect, February 28, 2020. https://doi.org/10.1016/j.cmi.2020.01.025.

PMID
32114010
Full Text

Souli, Maria, Felicia Ruffin, Seong-Ho Choi, Lawrence P. Park, Shengli Gao, Nicholas Christopoulos Lent, Batu K. Sharma-Kuinkel, et al. “Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.” Clin Infect Dis 69, no. 11 (November 13, 2019): 1868–77. https://doi.org/10.1093/cid/ciz112.

PMID
31001618
Full Text

Mba Medie, Felix, Batu K. Sharma-Kuinkel, Felicia Ruffin, Liana C. Chan, Maura Rossetti, Yu-Ling Chang, Lawrence P. Park, et al. “Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients.” Proc Natl Acad Sci U S A 116, no. 40 (October 1, 2019): 20087–96. https://doi.org/10.1073/pnas.1909849116.

PMID
31527248
Full Text

Mikkaichi, Tsuyoshi, Michael R. Yeaman, Alexander Hoffmann, and Alexander MRSA Systems Immunobiology Group. “Identifying determinants of persistent MRSA bacteremia using mathematical modeling.” Plos Comput Biol 15, no. 7 (July 2019): e1007087. https://doi.org/10.1371/journal.pcbi.1007087.

PMID
31295255
Full Text

Eichenberger, Emily M., and Joshua T. Thaden. “Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria.” Antibiotics (Basel) 8, no. 2 (April 6, 2019). https://doi.org/10.3390/antibiotics8020037.

PMID
30959901
Full Text

Thaden, Joshua T., Karen Chiswell, Ian Jaffe, Stephen P. Bergin, William E. Yang, Andrew Romaine, Jamie Roberts, et al. “Pediatric Antibacterial and Antifungal Trials From 2007 to 2017.” Pediatrics 142, no. 3 (September 2018). https://doi.org/10.1542/peds.2017-1849.

PMID
30158197
Full Text

Jaslow, Sarah L., Kyle D. Gibbs, W Florian Fricke, Liuyang Wang, Kelly J. Pittman, Mark K. Mammel, Joshua T. Thaden, et al. “Salmonella Activation of STAT3 Signaling by SarA Effector Promotes Intracellular Replication and Production of IL-10.” Cell Rep 23, no. 12 (June 19, 2018): 3525–36. https://doi.org/10.1016/j.celrep.2018.05.072.

PMID
29924996
Full Text

Thaden, Joshua T., Monica Gandhi, Hideaki Okochi, Christopher B. Hurt, and Mehri S. McKellar. “Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination.” Aids 32, no. 9 (June 1, 2018): F1–4. https://doi.org/10.1097/QAD.0000000000001825.

PMID
29683856
Full Text

Thaden, Joshua T., Lawrence P. Park, Stacey A. Maskarinec, Felicia Ruffin, Vance G. Fowler, and David van Duin. “Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.” Antimicrob Agents Chemother 61, no. 6 (June 2017). https://doi.org/10.1128/AAC.02671-16.

PMID
28373189
Full Text

Thaden, Joshua T., Jason M. Pogue, and Keith S. Kaye. “Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.” Virulence 8, no. 4 (May 19, 2017): 403–16. https://doi.org/10.1080/21505594.2016.1207834.

PMID
27384881
Full Text

Pages